Evidence mapPaperPMID 39705218Full record

ArticlePLOS global public health2024

Disparities in kidney care in vulnerable populations: A multinational study from the ISN-GKHA.

Robin L Erickson, Nivedita Kamath, Arpana Iyengar, Adebowale Ademola, Christopher Esezobor, Rowena Lalji, Erin Hedin, Silvia Arruebo, Fergus J Caskey, Sandrine Damster and 10 more

Abstract read
In one paragraph

Article in PLOS global public health, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed.

  1. Article
  2. Article
  3. Challenges Facing Contemporary Pediatric Nephrology: A Call to Global Advocacy.Clinical journal of the American Society of Nephrology : CJASN · 2026
    Article
  4. Article
  5. Article
  6. Article
  7. Little kidneys amid large global inequities.Pediatric nephrology (Berlin, Germany) · 2026
    Review
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

20 authors.

Robin L EricksonPaediatric Kidney Service, Starship Children's Hospital, University of Auckland, Auckland, New Zealand.ORCID https://orcid.org/0000-0002-3945-6158
Nivedita KamathDepartment of Pediatric Nephrology, St. John's Medical College Hospital, Bangalore, India.
Arpana IyengarDepartment of Paediatric Nephrology, St.John's National Academy of Health Sciences, Bangalore, India.
Adebowale AdemolaDepartment of Paediatrics, Faculty of Clinical Sciences, College of Medicine, University of Ibadan / University College Hospital Ibadan, Ibadan, Oyo State, Nigeria.ORCID https://orcid.org/0000-0001-9465-2744
Christopher EsezoborDepartment of Paediatrics, Faculty of Clinical Sciences, College of Medicine, University of Lagos, Lagos, Nigeria.
Rowena LaljiCentre for Kidney Disease Research, University of Queensland, Brisbane, Queensland, Australia.
Erin HedinDivision of Pediatric Nephrology, Department of Pediatrics, University of Alberta, Edmonton, Alberta, Canada.ORCID https://orcid.org/0000-0002-4685-0612
Silvia ArrueboThe International Society of Nephrology, Brussels, Belgium.
Fergus J CaskeyPopulation Health Sciences, Bristol Medical School, University of Bristol, Bristol, United Kingdom.ORCID https://orcid.org/0000-0002-5199-3925
Sandrine DamsterThe International Society of Nephrology, Brussels, Belgium.
Jo-Ann DonnerThe International Society of Nephrology, Brussels, Belgium.ORCID https://orcid.org/0000-0002-5005-909X
Vivekanand JhaGeorge Institute for Global Health, University of New South Wales (UNSW), New Delhi, India.ORCID https://orcid.org/0000-0002-8015-9470
Adeera LevinDivision of Nephrology, Department of Medicine, University of British Columbia, Vancouver, British Columbia, Canada.
Masaomi NangakuDivision of Nephrology and Endocrinology, The University of Tokyo Graduate School of Medicine, Tokyo, Japan.ORCID https://orcid.org/0000-0001-7401-2934
Syed SaadDivision of Nephrology and Immunology, Faculty of Medicine and Dentistry, University of Alberta, Edmonton, Alberta, Canada.
Marcello TonelliDepartment of Medicine, University of Calgary, Calgary, Alberta, Canada.
Feng YeDivision of Nephrology and Immunology, Faculty of Medicine and Dentistry, University of Alberta, Edmonton, Alberta, Canada.
Ikechi G OkpechiDivision of Nephrology and Immunology, Faculty of Medicine and Dentistry, University of Alberta, Edmonton, Alberta, Canada.ORCID https://orcid.org/0000-0002-6545-9715
Aminu K BelloDivision of Nephrology and Immunology, Faculty of Medicine and Dentistry, University of Alberta, Edmonton, Alberta, Canada.
David W JohnsonCentre for Kidney Disease Research, University of Queensland, Brisbane, Queensland, Australia.ORCID https://orcid.org/0000-0001-5491-3460

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Vulnerable populations, such as the elderly, children, displaced people, and refugees, often encounter challenges in accessing healthcare. In this study, we used data from the third iteration of the International Society of Nephrology Global Kidney Health Atlas (ISN-GKHA) to describe kidney care access and delivery to vulnerable populations across countries and regions. Using data from an international survey of clinicians, policymakers, and patient advocates, we assessed the funding and coverage of vulnerable populations on all aspects of kidney replacement therapies (KRT). Overall, 167 countries or jurisdictions participated in the survey, representing 97.4% of the world's population. Children had less access than adults to KRT: hemodialysis (HD) in 74% of countries, peritoneal dialysis (PD) in 53% of countries, and kidney transplantation (KT) in 80% of countries. Available nephrologist workforce for pediatric kidney care was much lower than for adults (0.69 per million population [pmp] vs 10.08 pmp). Refugees or displaced people with kidney failure did not have access to HD, PD, or KT in 21%, 33%, and 37% of the participating countries, respectively. Low-income countries (LICs) were less likely to provide KRT access to refugees compared to high-income countries (HICs): HD: 13% vs 22%; PD: 19% vs 61%; KT: 30% vs 44%. Testing for kidney disease was routinely offered to elderly people in only 61% of countries: LICs (45%), lower-middle-income countries (56%), upper-middle-income countries (54%), and HICs (75%). Equitable access to kidney care for vulnerable people, particularly for children and displaced people, remains an area of unmet need. Strategies are needed to address this issue.

Identifiers

PMID39705218
PMCPMC11661587

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.